Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lynch

Showing results (831-840 of 929) with videos related to

Pageof 93
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
MYC is amplified in BRCA1-associated breast cancersTatyana A Grushko, James J Dignam, Soma Das, et al.
Annals of Surgical Oncology|June 7, 2013
International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriersJohn Semple, Kelly A Metcalfe, Henry T Lynch, et al.
British Journal of Cancer|April 12, 2019
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutationKelly Metcalfe, Andrea Eisen, Leigha Senter, et al.
European Journal of Neurology|March 20, 2010
EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementiasJ-M Burgunder, J Finsterer, Z Szolnoki, et al.
Breast Cancer Research and Treatment|February 7, 2018
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJacqueline Lammert, Jan Lubinski, Jacek Gronwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null TumorsJames T Lynch, Urszula M Polanska, Oona Delpuech, et al.
The Lancet. Oncology|March 3, 2006
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort studySusan M Domchek, Tara M Friebel, Susan L Neuhausen, et al.
Cancers|February 11, 2023
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United StatesAmro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, et al.
European Journal of Neurology|May 28, 2009
EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystoniasH F Harbo, J Finsterer, J Baets, et al.
Journal of the National Cancer Institute|September 25, 2008
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriersAndrea Eisen, Jan Lubinski, Jacek Gronwald, et al.
Pageof 93

Showing results (831-840 of 929) with videos related to

Sort By:
Pageof 93
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
MYC is amplified in BRCA1-associated breast cancersTatyana A Grushko, James J Dignam, Soma Das, et al.
Annals of Surgical Oncology|June 7, 2013
International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriersJohn Semple, Kelly A Metcalfe, Henry T Lynch, et al.
British Journal of Cancer|April 12, 2019
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutationKelly Metcalfe, Andrea Eisen, Leigha Senter, et al.
European Journal of Neurology|March 20, 2010
EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementiasJ-M Burgunder, J Finsterer, Z Szolnoki, et al.
Breast Cancer Research and Treatment|February 7, 2018
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJacqueline Lammert, Jan Lubinski, Jacek Gronwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null TumorsJames T Lynch, Urszula M Polanska, Oona Delpuech, et al.
The Lancet. Oncology|March 3, 2006
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort studySusan M Domchek, Tara M Friebel, Susan L Neuhausen, et al.
Cancers|February 11, 2023
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United StatesAmro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, et al.
European Journal of Neurology|May 28, 2009
EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystoniasH F Harbo, J Finsterer, J Baets, et al.
Journal of the National Cancer Institute|September 25, 2008
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriersAndrea Eisen, Jan Lubinski, Jacek Gronwald, et al.
Pageof 93